Keynote: DRAGON project - COVID-19 Pandemic: where do we stand now?
C. Brightling (Leicester, United Kingdom), W. Vos (Tongeren, Belgium)
|  |
Epidemiology of acute COVID-19 infection
A. Torres Marti (Barcelona, Spain)
| |
Epidemiology of Long COVID
G. Rohde (Frankfurt, Germany)
| |
Epidemiology of acute and long COVID in children
A. Möller (Zurich, Switzerland)
| |
Epidemiology - Roundtable discussion and Q&A
| |
Pathophysiology of acute COVID-19
M. Shankar-Hari (Edinburgh, United Kingdom)
| |
Pathophysiology of Long COVID
K. Antoniou (Heraklion, Greece)
| |
Pathophysiology of acute and long COVID in children
F. Brinkmann (Bochum, Germany)
| |
Pathophysiology - Roundtable discussion and Q&A
| |
Management of acute COVID-19
N. Roche (Paris, France)
| |
Management of Long COVID
R. Evans (Leicester, United Kingdom)
| |
Management of acute and long COVID in children
C. Kosterink-Brackel (Voorburg, Netherlands)
| |
Management - Roundtable discussion and Q&A
| |
Workshop introduction and Q&A
S. Wagers (Maasmechelen, Belgium)
| |
Breakout group 1
K. Howard (Ann Arbor, USA), Rebecca Baker (Austin, USA)
| |
Breakout group 3
P. Powell (Sheffield, United Kingdom)
| |
Breakout group 4
J. Schofield (Southampton, United Kingdom)
| |
Wrap-up and closing remarks
S. Wagers (Maasmechelen, Belgium)
| |